Bing-Zong Li

3.8k total citations
153 papers, 3.0k citations indexed

About

Bing-Zong Li is a scholar working on Electrical and Electronic Engineering, Atomic and Molecular Physics, and Optics and Molecular Biology. According to data from OpenAlex, Bing-Zong Li has authored 153 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Electrical and Electronic Engineering, 72 papers in Atomic and Molecular Physics, and Optics and 45 papers in Molecular Biology. Recurrent topics in Bing-Zong Li's work include Semiconductor materials and interfaces (71 papers), Semiconductor materials and devices (48 papers) and Silicon and Solar Cell Technologies (36 papers). Bing-Zong Li is often cited by papers focused on Semiconductor materials and interfaces (71 papers), Semiconductor materials and devices (48 papers) and Silicon and Solar Cell Technologies (36 papers). Bing-Zong Li collaborates with scholars based in China, Belgium and United States. Bing-Zong Li's co-authors include Guo-Ping Ru, Xin-Ping Qu, Wenzhuo Zhuang, R.L. Van Meirhaeghe, Christophe Detavernier, Shiyang Zhu, Qi Xie, Yu-Long Jiang, F. Cardon and Jinxiang Fu and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Bing-Zong Li

143 papers receiving 2.9k citations

Peers

Bing-Zong Li
Y. Fujikawa Japan
Laura L. Smith United States
Masanobu Haraguchi Japan
Eisuke Arai Japan
Xuefeng Jiang China
Luca Tirinato Italy
Pan Wu China
J. Szatkowski Poland
Lai Mun Wong Singapore
David W. Schmidtke United States
Y. Fujikawa Japan
Bing-Zong Li
Citations per year, relative to Bing-Zong Li Bing-Zong Li (= 1×) peers Y. Fujikawa

Countries citing papers authored by Bing-Zong Li

Since Specialization
Citations

This map shows the geographic impact of Bing-Zong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing-Zong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing-Zong Li more than expected).

Fields of papers citing papers by Bing-Zong Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bing-Zong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing-Zong Li. The network helps show where Bing-Zong Li may publish in the future.

Co-authorship network of co-authors of Bing-Zong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Bing-Zong Li. A scholar is included among the top collaborators of Bing-Zong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bing-Zong Li. Bing-Zong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yin, Peihao, Yuchen Zhang, Chuan He, et al.. (2025). Targeting fucosyltransferase FUT8 as a prospective therapeutic approach for DLBCL. Oncogenesis. 14(1). 1–1.
2.
Cao, Dan, et al.. (2025). The histone demethylase KDM5C enhances the sensitivity of acute myeloid leukemia cells to lenalidomide by stabilizing cereblon. Cellular & Molecular Biology Letters. 30(1). 14–14. 1 indexed citations
3.
Li, Qi, Xinyun Zhang, Zhiming Wang, et al.. (2024). Anti-BCMA–engineered exosomes for bortezomib-targeted delivery in multiple myeloma. Blood Advances. 8(18). 4886–4899. 7 indexed citations
4.
Gao, Fan, Yuchen Zhang, Qi Li, et al.. (2024). BCL6 confers resistance to HDAC inhibitors in DLBCL. Biochemical Pharmacology. 227. 116466–116466. 1 indexed citations
5.
Song, Sha, Weimin Zhang, Qi Li, et al.. (2023). Dysregulation of alternative splicing contributes to multiple myeloma pathogenesis. British Journal of Cancer. 128(6). 1086–1094. 1 indexed citations
6.
Chen, Ping, Han Zhang, Liying Zhang, et al.. (2023). IGH::CD274 (PD‐L1) rearrangement in diffuse large B cell lymphoma and its therapeutic implication. SHILAP Revista de lepidopterología. 4(2). 442–445. 2 indexed citations
7.
Su, Qi, Qi Li, Weimin Zhang, Bing-Zong Li, & Wenzhuo Zhuang. (2022). Integrative analysis of enrichment and prognostic value of ferroptosis-related genes and pathways in multiple myeloma. Carcinogenesis. 43(11). 1050–1058. 6 indexed citations
8.
Ji, Jiali, Li Zhu, Qing Jiang, et al.. (2022). Analysis of m6A-related signatures associated with the tumor immune microenvironment and predict survival in acute myeloid leukemia. Annals of Translational Medicine. 10(16). 902–902. 6 indexed citations
9.
Liu, Xiaoqing, et al.. (2022). Clinical characteristics and outcomes of 100 adult patients with pure red cell aplasia. Annals of Hematology. 101(7). 1493–1498. 5 indexed citations
10.
Song, Sha, Fan Gao, Qi Li, et al.. (2021). IDH2 contributes to tumorigenesis and poor prognosis by regulating m6A RNA methylation in multiple myeloma. Oncogene. 40(35). 5393–5402. 28 indexed citations
11.
Song, Sha, Ji Zhang, Qi Su, et al.. (2021). Downregulation of ITGA6 confers to the invasion of multiple myeloma and promotes progression to plasma cell leukaemia. British Journal of Cancer. 124(11). 1843–1853. 14 indexed citations
12.
13.
Xu, Hongxia, Huiying Han, Sha Song, et al.. (2019). Exosome-Transmitted PSMA3 and PSMA3-AS1 Promote Proteasome Inhibitor Resistance in Multiple Myeloma. Clinical Cancer Research. 25(6). 1923–1935. 106 indexed citations
14.
Wang, Min, Fengtao You, Xingbing Wang, et al.. (2019). Automation Platform for CAR-T Manufacturing: The Benefits and the Clinical Outcomes. Blood. 134(Supplement_1). 1960–1960. 4 indexed citations
15.
Li, Bing-Zong, Huiying Han, Sha Song, et al.. (2018). HOXC10 Regulates Osteogenesis of Mesenchymal Stromal Cells Through Interaction with Its Natural Antisense Transcript lncHOXC-AS3. Stem Cells. 37(2). 247–256. 32 indexed citations
16.
Zhang, Xinyan, Bing-Zong Li, Huiying Han, et al.. (2018). Predicting multi-level drug response with gene expression profile in multiple myeloma using hierarchical ordinal regression. BMC Cancer. 18(1). 551–551. 10 indexed citations
17.
Li, Bing-Zong, Jinxiang Fu, Ping Chen, et al.. (2015). The Nuclear Factor (Erythroid-derived 2)-like 2 and Proteasome Maturation Protein Axis Mediate Bortezomib Resistance in Multiple Myeloma. Journal of Biological Chemistry. 290(50). 29854–29868. 60 indexed citations
18.
Li, Bing-Zong, et al.. (2010). Impairment in Immunomodulatory Function of Mesenchymal Stem Cells from Multiple Myeloma Patients. Archives of Medical Research. 41(8). 623–633. 33 indexed citations
19.
Li, Bing-Zong, Mingxia Shi, Jing Li, et al.. (2007). Elevated Tumor Necrosis Factor- α Suppresses TAZ Expression and Impairs Osteogenic Potential of Flk-1 + Mesenchymal Stem Cells in Patients with Multiple Myeloma. Stem Cells and Development. 16(6). 921–930. 58 indexed citations
20.
Li, Jing, Mingxia Shi, Ying Cao, et al.. (2006). Knockdown of hypoxia-inducible factor-1α in breast carcinoma MCF-7 cells results in reduced tumor growth and increased sensitivity to methotrexate. Biochemical and Biophysical Research Communications. 342(4). 1341–1351. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Y. Fujikawa Breakdown of academic impact, for papers by Laura L. Smith Breakdown of academic impact, for papers by Masanobu Haraguchi Breakdown of academic impact, for papers by Eisuke Arai Breakdown of academic impact, for papers by Xuefeng Jiang Breakdown of academic impact, for papers by Luca Tirinato Breakdown of academic impact, for papers by Pan Wu Breakdown of academic impact, for papers by J. Szatkowski Breakdown of academic impact, for papers by Lai Mun Wong Breakdown of academic impact, for papers by David W. Schmidtke
Rankless by CCL
2026